Purpose of Review

The purpose of this review is to summarize the up-to-date pain management options and recommendations for the challenging disease, endometriosis.

Recent Findings

The mainstays of endometriosis advances of both surgical and medical management continue to evolve. Experimental pharmaceuticals include Gestirone, and aromatase inhibitors have shown promise but are still under scrutiny. Surgical techniques include laparoscopic uterosacral nerve ablation/resection and presacral neurectomy.

Summary

No studies have directly compared medical versus surgical management, and as such, no one treatment modality can be recommend as superior to the other. Patients may initially be given a medical diagnosis and treated with nonsteroidal anti-inflammatory drugs, neurolepitcs, OCP, GNRH agonists/antagonists, and Danazol. Assessing the success of these regimens has proved difficult. Surgical management relies on various methods including excision/ablation of the lesions, nerve ablation, neurectomy, hysterectomy, and oophorectomy.

中文翻译：

---

子宫内膜异位症疼痛管理：审查。

审查目的

这篇综述的目的是总结针对挑战性疾病子宫内膜异位症的最新疼痛管理方案和建议。

最近的发现

子宫内膜异位症在外科和医疗管理方面的进步不断发展。实验药物包括Gestirone，芳香酶抑制剂已显示出希望，但仍在审查中。手术技术包括腹腔镜子宫ros神经切除/切除和pre神经切除术。

概要

没有研究直接比较药物治疗和外科治疗，因此，没有一种治疗方法可推荐优于其他方法。最初可能会给患者进行医学诊断，并用非甾体类抗炎药，神经脂蛋白，OCP，GNRH激动剂/拮抗剂和达那唑治疗。评估这些方案的成功已证明是困难的。手术管理依赖于各种方法，包括病变的切除/消融，神经消融，神经切除术，子宫切除术和卵巢切除术。